Objective —To determine the efficacy of nicotinamide in inducing remission in early-onset insulin-dependent diabetes mellitus. Research Design and Methods —This study was a double-blind, randomized clinical trial. Results —Nicotinamide failed to induce remission or differences on β-cell secretion between the two groups.
